THE European Medicines Agency
has released the first guideline in
the European Union on clinical
investigation of medicines for the
treatment of lupus erythematosus
for public consultation.The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 13 Mar 13 To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 13 Mar 13
CONSUMERS and health professionals are advised that Biogen Australia, in consultation with the Therapeutic Goods Administration (TGA), will withdraw multiple sclerosis therapy Zinbryta (daclizumab) from the Australian market following a review of cases of serious inflammatory brain disorders in Europe (PD 05 Mar).